Our Science – Polizzotto Website
Mark N. Polizzotto, M.B., B.S., B.Med.Sc
Selected Publications |
 |
| 1)
Polizzotto MN, Uldrick TS, Hu D, Yarchoan R. Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. Front Microbiol. 3: 73, 2012. [Journal] |
|
| 2)
Gasperini P, Espigol-Frigole G, McCormick PJ, Salvucci O, Maric D, Uldrick TS, Polizzotto MN, Yarchoan R, Tosato G. Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res. 72: 1157-69, 2012. [Journal] |
|
| 3)
Uldrick TS, Wyvill KM, Kumar P, O'Mahony D, Bernstein W, Aleman K, Polizzotto MN, Steinberg SM, Pittaluga S, Marshall V, Whitby D, Little RF, Yarchoan R. Phase II Study of Bevacizumab in Patients With HIV-Associated Kaposi's Sarcoma Receiving Antiretroviral Therapy. J. Clin. Oncol. 30: 1476-83, 2012. [Journal] |
|
| 4)
Uldrick TS, Polizzotto MN, Yarchoan R. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr Opin Oncol. 24: 495-505, 2012. [Journal] |
|
| 5)
Ray A, Marshall V, Uldrick T, Leighty R, Labo N, Wyvill K, Aleman K, Polizzotto MN, Little RF, Yarchoan R, Whitby D. Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus (KSHV) MicroRNAs in Patients with Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome. J. Infect. Dis. 205: 1665-76, 2012. [Journal] |
|
| 6)
Uldrick TS, Polizzotto MN, Aleman K, O'Mahony D, Wyvill KM, Wang V, Marshall V, Pittaluga S, Steinberg SM, Tosato G, Whitby D, Little RF, Yarchoan R. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood. 117: 6977-86, 2011. [Journal] |
|
| 7)
McQuilten ZK, Schembri N, Polizzotto MN, Akers C, Wills M, Cole-Sinclair MF, Whitehead S, Wood EM, Phillips LE. Hospital blood bank information systems accurately reflect patient transfusion: results of a validation study. Transfusion. 51: 943-8, 2011. [Journal] |
|
| 8)
Polizzotto MN, Skinner M, Cole-Sinclair MF, Opat SS, Spencer A, Avery S. Allo-SCT for hematological malignancies in the setting of HIV. Bone Marrow Transplant. 45: 584-6, 2010. [Journal] |
|
| 9)
Polizzotto MN, Jones P, Cameron PU, Spelman D, Woolley IJ. The influence of splenectomy on the infectious complications and outcomes of people with HIV: marked, sustained elevation in risk of severe infection with bacteria including Streptococcus pneumoniae. J. Acquir. Immune Defic. Syndr. 55: e24-6, 2010. [Journal] |
|
| 10)
Shortt J, Polizzotto MN, Waters N, Borosak M, Moran M, Comande M, Devine A, Jolley DJ, Wood EM. Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell use. Transfusion. 49: 2296-303, 2009. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 5/6/2013.
